KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other Non-Current Liabilities (2016 - 2025)

Biogen (BIIB) has 17 years of Other Non-Current Liabilities data on record, last reported at $748.5 million in Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 2.21% year-over-year to $748.5 million; the TTM value through Dec 2025 reached $748.5 million, up 2.21%, while the annual FY2025 figure was $748.5 million, 2.21% up from the prior year.
  • Other Non-Current Liabilities reached $748.5 million in Q4 2025 per BIIB's latest filing, down from $799.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $1.4 billion in Q1 2021 and bottomed at $556.7 million in Q2 2024.
  • Average Other Non-Current Liabilities over 5 years is $991.8 million, with a median of $935.5 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 37.58% in 2023, then soared 43.63% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $1.3 billion in 2021, then dropped by 28.5% to $944.2 million in 2022, then fell by 17.27% to $781.1 million in 2023, then decreased by 6.25% to $732.3 million in 2024, then grew by 2.21% to $748.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $748.5 million in Q4 2025, $799.6 million in Q2 2025, and $732.3 million in Q4 2024.